Defining the role of post-mastectomy radiotherapy: The new evidence

ONCOLOGY

Volumn 10, Issue 7, 1996, Pages 991-1002

  Pierce, Lori J ^a   Lichter, Allen S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEART; HUMAN; MASTECTOMY; META ANALYSIS; PATIENT CARE PLANNING; RADIATION DOSE; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; MASTECTOMY; PATIENT CARE PLANNING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030183345     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Halverson K, Perez C, Kuske R, et al: Isolated local-regional recurrence of breast cancer following mastectomy: Radiotherapeutic management. Int J Radiat Oncol Biol Phys 19:851-858, 1990.
2. Schwaibold F, Fowble BL, Solin LJ, et al: The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 21:299-310, 1991.
3. Toonkel L, Fix I, Jacobson L, et al: The significance of local-regional recurrence of carcinoma of the breast. Int J Radiat Oncol Biol Phys 9:33-39, 1983.
4. Donegan WL, Perez-Mesa CM, Watson FR: A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet 122:529-540, 1966.
5. Bedwinek J: Natural history and management of isolated local-regional recurrence following mastectomy. Semin Radiat Oncol 4:260-269, 1994.
6. Haagensen CD, Bodian C: A personal experience with Halsted's radical mastectomy. Ann Surg 199:143-150, 1984.
7. Arriagada R, Rutqvist LE, Mattson A, et al: Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 13:2869-2878, 1995.
8. Rosenman J, Bernard S, Kober C, et al: Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital (1970-1982). Cancer 57:1421-1425, 1986.
9. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy: Analysis of 716 consecutive patients. Cancer 41:1170-1178, 1978.
10. Houghton J, Baum M, Haybittle JL: Role of radiotherapy following total mastectomy in patients with early breast cancer: The Closed Trials Working Party of the CRC Breast Cancer Trials Group. World J Surg 18:117-122, 1994.
11. Mentzer SJ, Osteen RT, Wison RE: Local recurrence and the deep resection margin in carcinoma of the breast. Surg Gynecol Obstet 163:513-517, 1986.
12. O'Rourke S, Galea MH, Morgan D, et al: Local recurrence after simple mastectomy. Br J Surg 81:386-389, 1994.
13. Fowble B, Glick J, Goodman R: Radiotherapy for the prevention of local-regional recurrence in high rish patients post mastectomy receiving adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 15:627-631, 1988.
14. Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681, 1985.
15. Fisher B, Anderson S, Redmond C, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456-1461, 1995.
16. Hellman S: Natural history of small breast cancers (Karnofsky memorial lecture). J Clin Oncol 12:2229-2234, 1994.
17. Jones JM, Ribeiro GG: Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 40:204-208, 1989.
18. Host H, Brennhovd IO, Loeb M, et al: Postoperative radiotherapy in breast cancer - long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12:727-732, 1986.
19. Fisher B, Slack NH, Cavanaugh PJ, et al: Postoperative radiotherapy in the treatment of breast cancer: Results of the NSABP clinical trial. Ann Surg 172:711-732, 1970.
20. Rutqvist LE, Pettersson D, Johansson H: Adjuvant radiation therapy versus surgery alone in operable breast cancer: Long-term follow-up of a randomized clinical trial. Radiother Oncol 26:104-110, 1993.
21. Lythgoe JP, Palmer MK: Manchester regional breast study - 5 and 10 year results. Br J Surg 69:693-696, 1982.
22. Turnbull AR, Turner DT, Chant AD, et al: Treatment of early breast cancer. Lancet 2:7-9, 1978.
23. Forrest AP, Stewart HJ, Roberts MM, et al: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196:371-378, 1982.
24. Fletcher GH: Clinical dose-response curves of human malignant epithelial tumours. Br J Radiol 46:1-12, 1973.
25. Cuzick J, Stewart H, Peto R, et al: Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71:15-29, 1987.
26. Cuzick J, Stewart H Rutqvist, L, et al: Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447-453, 1973.
27. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 333:1444-1455, 1995.
28. Richards MA, O'Reilly, SM, Howell A, et al: Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: An update of the Guy's/ Manchester trial. J Clin Oncol 8:2032-2039, 1990.
29. Fisher B, Fisher ER, Redmond C: Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol 14:929-941, 1986.
30. Morrison JM, Howell A, Kelly KA, et al: West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: Results after a median follow-up of 7 years. Br J Cancer 60.911-918, 1989.
31. Bonadonna G, Valagussa P, Molitern A, et al: Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up. N Engl J Med 332.901-906, 1995.
32. Marks LB, Halperin EC, Prosnitz LR, et al. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes: Cancer and Leukemia Group B. Int J Radiat Oncol Biol Phys 23:1021-1026, 1992
33. Peters W, Ross M, Vredenburgh J, et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132-1132, 1993.
34. Castiglione-Gertsch M, Johnsen C, Goldhirsch A, et al: The International (Ludwig) Breast Cancer Study Group trials I-IV: 15 years follow-up. Ann Oncol 5:717-724, 1994.
35. Rutqvist LE, Cedermark B, Glas V, et al: Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer Cancer 66:89-96, 1990.
36. Stefanik D, Goldberg R, Byrne P, et al: Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 3:660-665, 1985.
37. Fowble B, Gray R, Gilchrist K, et al: Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. Cancer 6:1107-1117, 1988.
38. Pisansky TM, Ingle JN, Schaid DJ, et al: Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer: Impact of clinical, histopathologic, and flow cytometric factors. Cancer 72:1247-1260, 1993.
39. Sykes HF, Sim DA, Wong CJ, et al: Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: evaluation of the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 16:641-647, 1989.
40. Martinez A, Ahmann D, O'Fallow J, et al: An interim analysis of the randomized surgical adjuvant trial for patients with unfavorable breast cancer. Int J Radiat Oncol Biol Phys 10(suppl 2):106, 1984.
41. McArdle CS, Crawford D, Dykes EH, et al: Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73:264-266, 1986.
42. Muss H, Cooper R, Brockschmidt J, et al: A randomized trial of adjuvant chemotherapy with and without radiation therapy for stage II breast cancer: 11 year follow-up of Piedmont Oncology Association protocol 74176. Breast Cancer Res Treat 14:185, 1989.
43. Griem KL, Henderson IC, Gelman R, et al: The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 5:1546-1555, 1987.
44. Blomqvist C, Tiusanen K, Elomaa I, et al: The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer: Long-term follow-up results of a randomised trial. Br J Cancer 66:1171-1176, 1992.
45. Velez-Garcia E, Carpenter JT, Moore M, et al: Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: A Southeastern Cancer Study Group trial. Eur J Cancer 11:1833-1837, 1992.
46. Buzdar AU, Blumenshein GR, Smith TL, et al: Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without irradiation in operable breast cancer: A prospective randomized trial. Cancer 53:384-389, 1984.
47. Ragaz J, Jackson SM, Le N, et al: Can adjuvant locoregional radiotherapy reduce systematic recurrence in stage I-II breast cancer patients? Recurrence analysis of the British Columbia randomized trial (abstract). Proc Am Soc Clin Oncol 15: A150, 1996.
48. Overgaard M: The role of postmastectomy radiotherapy in high-risk breast cancer patients receiving adjuvant systemic therapy. 5th International Meeting of Progress in Radio-Oncology ICRO/OGRO, p 41-45. Bologna (Italy), Monduzzi Editore, 1995.
49. Overgaard M, Christensen JJ, Johansen H, et al: Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 19:1121-1124, 1990.
50. Lara Jimenez P, Garcia Puche J, Pedraza V: Adjuvant combined modality treatment in high risk breast cancer patients: 10 year results. 5th EORTC Breast Cancer Working Conference, Leuven, Belgium, A293, 1991.
51. Pierce LJ, Lichter AS, Archer P: Indications, integration, and technical aspects of local-regional irradiation in the management of advanced breast cancer. Semin Radiat Oncol 4:242-253, 1994.
52. Danoff BF, Galvin JM, Cheg E, et al: The clinical application of CT scanning in the treatment of primary breast cancer, in Current Controversies in Breast Cancer, pp 391-397 Austin, Texas, University of Texas Press, 1984.
53. Shapiro CL, Recht A: Late effects of adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 16:101-112, 1994.
54. Harrigan P, Otis D, Recht A, et al: The effect of adjuvant radiation therapy on cardiac events in breast cancer patients treated with doxorubicin. Proc Am Soc Clin Oncol 14:102, 1995.
55. Hellman S, Weichselbaum R: Radiation oncology and the new biology. Cancer J Sci Am 1:174-179, 1995.